Exchange Traded Concepts LLC cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 3.0% in the fourth quarter, HoldingsChannel reports. The firm owned 86,109 shares of the pharmacy operator’s stock after selling 2,664 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Walgreens Boots Alliance were worth $803,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. First Financial Corp IN boosted its holdings in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares during the period. Strategic Investment Solutions Inc. IL acquired a new stake in Walgreens Boots Alliance in the second quarter valued at $34,000. TD Private Client Wealth LLC raised its stake in Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares in the last quarter. Sentry Investment Management LLC acquired a new stake in Walgreens Boots Alliance in the third quarter valued at $30,000. Finally, Eastern Bank acquired a new stake in Walgreens Boots Alliance in the third quarter valued at $33,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on WBA. Barclays raised their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Truist Financial raised their price target on Walgreens Boots Alliance from $10.00 to $13.00 and gave the company a “hold” rating in a research note on Thursday, January 16th. UBS Group raised their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Jefferies Financial Group cut their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Finally, Morgan Stanley cut their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $13.27.
Walgreens Boots Alliance Stock Performance
Shares of WBA stock opened at $11.25 on Thursday. The stock has a market capitalization of $9.72 billion, a PE ratio of -1.10, a price-to-earnings-growth ratio of 1.46 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $23.76. The stock’s 50-day moving average price is $9.96 and its 200 day moving average price is $9.86. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the previous year, the company earned $0.66 EPS. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Further Reading
- Five stocks we like better than Walgreens Boots Alliance
- What Are Dividend Achievers? An Introduction
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Steel Stocks Soaring After Tariff Announcements
- Stock Market Sectors: What Are They and How Many Are There?Â
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.